Filing Details

Accession Number:
0000711377-12-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-21 13:00:00
Reporting Period:
2012-05-19
Filing Date:
2012-05-21
Accepted Time:
2012-05-21 18:24:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-19 5,000 $18.19 825,329 No 4 M Direct
Common Stock Disposition 2012-05-19 5,000 $38.52 820,329 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2012-05-19 5,000 $0.00 5,000 $18.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
241,072 2013-08-15 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 194,320 Indirect See Footnote
Footnotes
  1. The options were NQs granted on 8/15/2008,and vest 20% each year for five years
  2. Shares are held in trust for Judith Herbert, spouse of James Herbert